NCATS has released the AR-TIN NOSI

NCATS has released a new Notice of Special Interest (NOSI) that is titled “Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)”.  NCATS, via the AR-TIN NOSI, invites applications that include proposals to design, develop, demonstrate, implement, and evaluate digital and non-digital innovative tools and resources to improve participant recruitment in clinical trials.

The link below can be used to access detailed information regarding the AR-TIN NOSI. Please feel free to share the link with any of your colleagues who may have an interest in submitting applications.

Link to the AR-TIN NOSI: